全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2013 

The Use of Biatain Ag in Hard-to-Heal Venous Leg Ulcers: Meta-Analysis of Randomised Controlled Trials

DOI: 10.1371/journal.pone.0067083

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Venous leg ulcers are common, troublesome, and their failure to heal is often related to a heavy bio-burden. Ionized silver has both anti-inflammatory and antimicrobial properties. The ulcer healing properties of the silver releasing foam dressing Biatain Ag has been examined in 4 randomized controlled trials (RCTs). Aim To evaluate ulcer healing through a meta-analytic approach after treatment with either Biatain Ag or a non-active dressing. Patients and Methods 685 subjects with pure or mixed hard-to-heal venous leg ulcers were included in the meta-analysis. Results Biatain Ag showed a significant treatment effect (p<0.0001), responder rate (p<0.001), and healing rate (p = 0.002). Conclusion The meta-analysis of the 4 RCTs provided statistical significant evidence to support the use of Biatain Ag dressing in treatment of hard-to-heal venous leg ulcers.

References

[1]  Mekkes JR, Loots MA, van der Wal AC, Bos JD (2003) Causes, investigation and treatment of leg ulceration. Br J Dermatol 148: 388–401.
[2]  Baker SR, Stacey MC, Singh G, Hoskin SE, Thompson PJ (1992) Aetiology of chronic leg ulcers. Eur J Vasc Surg 6: 245–251.
[3]  Cornwall JV, Dore CJ, Lewis JD (1986) Leg ulcers: epidemiology and aetiology. Br J Surg 73: 693–696.
[4]  Margolis DJ, Bilker W, Santanna J, Baumgarten M (2002) Venous leg ulcer: incidence and prevalence in the elderly. J Am Acad Dermatol 46: 381–386.
[5]  Ayello EA, Cuddigan JE (2004) Conquer chronic wounds with wound bed preparation. Nurse Pract 29: 8–25.
[6]  Davies CE, Hill KE, Newcombe RG, Stephens P, Wilson MJ, et al. (2007) A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Repair Regen 15: 17–22.
[7]  Dissemond J, Assadian O, Gerber V, Kingsley A, Kramer A, et al. (2011) Classification of wounds at risk and their antimicrobial treatment with polihexanide: a practice-oriented expert recommendation. Skin Pharmacol Physiol 24: 245–255.
[8]  Gray D, Barrett S, Battacharya M, Butcher M, Enoch S, et al. (2010) PHMB and its potential contribution to wound management. Wounds 6: 40–46.
[9]  Leaper D, Harding K (2010) Antimicrobials and Antiseptics. Journal of Wound Technology 7: 34–35.
[10]  Leaper D (2011) Topical antiseptics in wound care: time for reflection. Int Wound J 8: 547–549.
[11]  Leaper DJ (2006) Silver dressings: their role in wound management. Int Wound J 3: 282–294.
[12]  Leaper DJ, Schultz G, Carville K, Fletcher J, Swanson T, et al. (2012) Extending the TIME concept: what have we learned in the past 10 years. Int Wound J 9 Suppl 21–19.
[13]  International consensus. Appropriate use of silver dressings in wounds. An expert working group consensus. London: Wounds International. 2012. Available: http://www.woundsinternational.com/pdf/c?ontent_10381.pdf. Accessed 2013 May 23.
[14]  Vermeulen H, van Hattem JM, Storm-Versloot MN, Ubbink DT (2007) Topical silver for treating infected wounds. Cochrane Database Syst Rev CD005486.
[15]  White R, Cutting K (2006) Exploring the effects of silver in wound management - what is optimal? Wounds 18: 307–314.
[16]  Cutting K, White R, Edmonds M (2007) The safety and efficacy of dressings with silver - addressing clinical concerns. Int Wound J 4: 177–184.
[17]  Ip M, Lui SL, Chau SS, Lung I, Burd A (2006) The prevalence of resistance to silver in a Burns unit. J Hosp Infect 63: 342–344.
[18]  Lansdown AB (2002) Silver. I: Its antibacterial properties and mechanism of action. J Wound Care 11: 125–130.
[19]  Lansdown AB, Williams A (2007) Bacterial resistance to silver in wound care and medical devices. J Wound Care 16: 15–19.
[20]  Percival SL, Bowler P, Woods EJ (2008) Assessing the effect of an antimicrobial wound dressing on biofilms. Wound Repair Regen 16: 52–57.
[21]  Robson MC (1997) Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am 77: 637–650.
[22]  Hermans MH (2007) Silver-containing dressings and the need for evidence. Adv Skin Wound Care 20: 166–173.
[23]  Harding K, Gottrup F, Jawien A, Mikosinski J, Twardowska-Saucha K, et al. (2011) A prospective, multi-centre, randomised, open label, parallel, comparative study to evaluate effects of AQUACEL((R)) Ag and Urgotul((R)) Silver dressing on healing of chronic venous leg ulcers. Int Wound J 9: 285–294.
[24]  Jorgensen B, Price P, Andersen KE, Gottrup F, Bech-Thomsen N, et al. (2005) The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial. Int Wound J 2: 64–73.
[25]  Karlsmark T, Agerslev RH, Bendz SH, Larsen JR, Roed-Petersen J, et al. (2003) Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers. J Wound Care 12: 351–354.
[26]  Lazareth I, Ourabah Z, Senet P, Cartier H, Sauvadet A, et al. (2007) Evaluation of a new silver foam dressing in patients with critically colonised venous leg ulcers. J Wound Care 16: 129–132.
[27]  Munter KC, Beele H, Russell L, Crespi A, Grochenig E, et al. (2006) Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study. J Wound Care 15: 199–206.
[28]  Vanscheidt W, Lazareth I, Routkovsky-Norval C (2003) Safety evaluation of a new ionic silver dressing in the management of chronic ulcers. Wounds 15: 371–378.
[29]  Wunderlich U, Orfanos CE (1991) Treatment of venous ulcera cruris with dry wound dressings. Phase overlapping use of silver impregnated activated charcoal xerodressing. Hautartz 42: 446–450.
[30]  Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H (2010) Topical silver for preventing wound infection. Cochrane Database Syst Rev CD006478.
[31]  Lo SF, Hayter M, Chang CJ, Hu WY, Lee LL (2008) A systematic review of silver-releasing dressings in the management of infected chronic wounds. J Clin Nurs 17: 1973–1985.
[32]  Lo SF, Chang CJ, Hu WY, Hayter M, Chang YT (2009) The effectiveness of silver-releasing dressings in the management of non-healing chronic wounds: a meta-analysis. J Clin Nurs 18: 716–728.
[33]  Chambers H, Dumville JC, Cullum N (2007) Silver treatments for leg ulcers: a systematic review. Wound Repair Regen 15: 165–173.
[34]  Carter MJ, Tingley-Kelley K, Warriner RA III (2010) Silver treatments and silver-impregnated dressings for the healing of leg wounds and ulcers: a systematic review and meta-analysis. J Am Acad Dermatol 63: 668–679.
[35]  Humbert P, Zuccarelli F, Debure C, Vendeaud Busquet F, Bressieux JM, et al. (2006) Ulcères de jambe présentant des signes locaux d'infection: intérêt du pansement Biatain Argent [Leg ulcers showing local signs of infection: benefits of the Biatain Argent dressing]. Journal des plaies et cicatrisations 52: 41–47.
[36]  Senet P, Bause R, Jorgensen B, Fogh K (2013) Clinical efficacy of a silver-releasing foam dressing in venous leg ulcer healing - a randomized controlled trial. Int Wound J Epub ahead of print.
[37]  Flanagan M (2003) Wound measurement: can it help us to monitor progression to healing? J Wound Care 12: 189–194.
[38]  Moher D, Altman DG, Liberati A, Tetzlaff J (2011) PRISMA statement. Epidemiology 22: 128.
[39]  Tackling antibacterial resistance in Europe. European Academies Science Advisory Council. Royal Society. London. 2007. Available: http://www.easac.eu/fileadmin/PDF_s/repo?rts_statements/Tackling.pdf. Accessed 2013 May 23.
[40]  Leaper D, Drake R (2011) Should one size fit all? An overview and critique of the VULCAN study on silver dressings. Int Wound J 8: 1–4.
[41]  Gottrup F, Apelqvist J (2010) The challenge of using randomized trials in wound healing. Br J Surg 97: 303–304.
[42]  Leaper D (2009) Evidence-based wound care in the UK. Int Wound J 6: 89–91.
[43]  Leaper D (2009) Cochrane: hands off wound care. Int Wound J 6: 309–310.
[44]  Gottrup F, Apelqvist J (2012) Present and new techniques and devices in the treatment of DFU: a critical review of evidence. Diabetes Metab Res Rev 28 Suppl 164–71.
[45]  Michaels JA, Campbell WB, King BM, Macintyre J, Palfreyman SJ, et al.. (2009) A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial. Health Technol Assess 13: 1–114, iii.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133